FDA Inspection
Tulex Pharmaceuticals Inc.Tulex Pharmaceuticals Inc. – FDA Inspection, Nov 21, 2017
Record Details
This FDA Inspection record concerns Tulex Pharmaceuticals Inc., with an inspection on November 21, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a0867f8e-3b5f-4fc5-ad03-788d5b196185
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1031819
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Tulex Pharmaceuticals Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| December 5, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 29, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 14, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 5, 2018 | Not classified | New Jersey District Office |
Other documents for Tulex Pharmaceuticals Inc.
- FDA Inspection 1264812 - 2025-03-24
- FDA Inspection 1256966 - 2024-12-05
- FDA Inspection 1232755 - 2024-02-29
- FDA Inspection 1129002 - 2020-08-14
- FDA Inspection 1053140 - 2018-04-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.